endpoints and new targets for curing hepatitis b | stephen locarnini
Published 3 years ago • 289 plays • Length 33:35
Download video MP4
Download video MP3
Similar videos
-
31:08
new treatments/targets in hbv | stephen locarnini, bsc(hons), phd, mbbs, frc(path)
-
32:57
new tools for testing and monitoring hepatitis b and c | stephen locarnini
-
22:10
rationale for different virological targets in hbv | stephen locarnini, bsc(hons), phd, mbbs, frc
-
14:25
sb 9200: a novel rig-i agonist for chronic hepatitis b | stephen locarnini
-
20:46
strategy for the elimination of hepatitis b and c (academy of medicine report) | andrew aronsohn, md
-
18:27
consensus aasld-easl hbv treatment endpoint and hbv cure definition | anna s. lok, md, dsc
-
28:29
is host genome integrated hbv relevant? - the con perspective | stephen locarnini
-
17:53
update on new antiviral targets core capsid inhibitors (cpams) | kosh agarwal, md
-
15:33
targeting hbv core protein to clear infection and achieve higher cure rates | richard colonno
-
14:24
other virological mechanisms | stephen locarnini, bsc, phd, mbbs, frcp
-
14:42
update on new antiviral targets – non–capsid inhibitors | man fung yuen, md, phd, dsc
-
28:17
novel antiviral and immune targets to cure hbv - fabien zoulim
-
39:45
round table discussion: trial design, treatment endpoints and regulatory approach
-
21:23
new data from combination trials for chronic hepatitis b - pietro lampertico, md, phd
-
8:34
immunotherapeutics in the treatment of chronic hepatitis b - s. browne, md
-
28:56
what’s new in hepatitis b treatment & diagnostics | seng gee lim, mbbs, fracp, frcp, md
-
20:25
hepatitis b cure: from discovery to regulatory endpoints in hbv clinical research... | fabien zoulim
-
9:47
hbv case-when is it not acute hepatitis b? - panelist - stephen korsman, mbchb, fcpath(sa)viro, mmed
-
13:15
rationale for including immune tolerant and low viral load patients in new drug trials
Clip.africa.com - Privacy-policy